The Potential of Cancer Biomarkers : From Discovery to Clinical Application. Questo articolo non è disponibile.
Lingua: inglese
Editore: Elsevier Science Jun 2025, 2025
- Rilegato
- Nuovo
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Venditore AbeBooks dal 14 agosto 2006
Condizione: Nuovo
EUR 225,00
Descrizione dell’articolo da parte del venditore
Neuware - The Potential of Biomarkers: From Discovery to Clinical Application addresses the challenges related to knowledge dissemination, interdisciplinary understanding, diagnostic complexity, quality assurance, patient care, research advancement, education, and professional development within the field of clinical biochemistry. The book provides a holistic solution by offering comprehensive insights and practical guidance to a diverse audience, contributing to the enhancement of healthcare and biomedical research. Each chapter explores the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.Cancer biomarkers, the molecular signatures of cancer, hold immense promise in revolutionizing how we diagnose, treat, and personalize therapies for cancer patients. In this curated reference, esteemed contributors explore the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.…
Codice articolo 9780443292798
- Titolo
- The Potential of Cancer Biomarkers : From Discovery to Clinical Application
- Autore
- Pranav Kumar Prabhakar
- Editore
- Elsevier Science Jun 2025
- Anno di pubblicazione
- 2025
- Condizione
- Neu
- Rilegatura
- Buch
- Lingua
- inglese
- ISBN 10
- 0443292795
- ISBN 13
- 9780443292798
- Peso dell'articolo
- 975 grammi
- Dimensioni
- 239x200x25 mm
Cancer biomarkers, the molecular signatures of cancer, hold immense promise in revolutionizing how we diagnose, treat, and personalize therapies for cancer patients. In this curated reference, esteemed contributors explore the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.
"Riassunto" può appartenere a un’altra edizione di questo titolo.
Informazioni sull’autore
Pranav Kumar Prabhakar is Professor and Head of the Department of Biotechnology, School of Engineering and Technology, Nagaland University, Kohima, India. His research focuses on understanding molecular mechanisms involved in metabolic disorders, particularly diabetes, and on developing strategies for oral insulin delivery using natural products and biotechnology-based approaches. He is actively involved in research, academic mentoring, peer review, and editorial activities within the biomedical and biotechnology fields. His professional interests include translational research, signaling pathways associated with metabolic diseases, and the application of biotechnology to improve therapeutic outcomes. He contributes to scientific and academic initiatives that support advancements in biotechnology and healthcare research.
"Descrizione articolo" può appartenere a un’altra edizione di questo titolo.